Heptabarbital
Heptabarbital (Medomin) is an oral activity Barbituric acid derivative. Heptabarbital has the potential for the research of insomnia[1][2].
Product Specifications
CAS Number
509-86-4
Product Name Alternative
Medomin
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Field of Research
Neurological Disease
Smiles
O=C1NC(C(CC)(C2=CCCCCC2)C(N1)=O)=O
Molecular Formula
C13H18N2O3
Molecular Weight
250.29
References & Citations
[1]Hoffman A, et al. Gender differences in the pharmacodynamics of barbiturates in rats. Pharm Res. 1989 Nov;6 (11) :976-81.|[2]Breimer DD, et al. Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man. Eur J Clin Pharmacol. 1975 Dec 19;9 (2-3) :169-78.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RDR-SGPP2-Ra-01 96 Tests
Rat Sphingosine-1-Phosphate Phosphatase 2 (SGPP2) ELISA Kit
Sign In for Pricing
View Details RDR-SGPP2-Ra-02 48 Tests
Rat Sphingosine-1-Phosphate Phosphatase 2 (SGPP2) ELISA Kit
Sign In for Pricing
View Details 
BNC473786-500 1x 500 µL
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (rAKT1/2491), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 